Pricing Remdesivir; Instagram Co-Founder’s Covid Tracking Data
Squawk Pod
CNBC
4.2 • 543 Ratings
🗓️ 29 June 2020
⏱️ 35 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | This is Squawk Pod. I'm C. M. B. |
| 0:04.1 | producer Katie Kramer. Today on our podcast, Resources and Remdesifir has COVID-19 hits new spikes in the |
| 0:10.8 | U.S. Health officials and other Americans are looking to the |
| 0:14.6 | founder of Instagram for COVID data. Kevin Sistram's online case tracker RT. live is |
| 0:20.6 | getting some attention. This site is a public good. |
| 0:23.0 | It's not meant to be a new company. |
| 0:24.6 | It's not meant to be anything other than a resource for people to come and understand |
| 0:29.1 | how the virus is spreading near them. |
| 0:31.5 | And Gilead has priced Remdesophir, a drug that's so far proven to |
| 0:35.4 | effectively treat coronavirus patients. The drugmaker CEO Daniel O'Day |
| 0:39.4 | says despite concerns, this price is right. Most importantly, I think the way that we priced this |
| 0:44.9 | assures that patients will have access to this medicine, |
| 0:47.3 | regardless of how you're covered or not covered in the United States. |
| 0:51.0 | Those stories and advertisers unfriending Facebook. It's Monday, June 29th, 2020. |
| 0:57.0 | Four day week, four shortened days because they are getting shorter. |
| 1:01.0 | Squawk Pod begins right now. |
| 1:04.0 | Good morning everybody. |
| 1:06.0 | Welcome to Squawk Box here on C. |
| 1:08.0 | I'm Becky Quick along with Joe Cernan and Andrew Ross Sorkin. |
| 1:11.0 | But we are getting to the end of the month and that's when we start to |
| 1:13.4 | really take notice of what's been happening. The declines that we saw on |
| 1:16.4 | Friday push both the Dow and the S&P 500 into negative territory for the month of |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

